Brief Summary

Hypothesis: low-dose chest computed tomography, has the same accuracy for the diagnosis of pneumonia compared to the routine protocol. In total, 230 patients are planned to be enrolled in the study. Each patient will have 2 studies (routine chest CT and low-dose chest CT) sequentially during one visit to the computed tomography room.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2020

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 7, 2020

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2020

Completed
Last Updated

June 12, 2020

Status Verified

May 1, 2020

Enrollment Period

27 days

First QC Date

April 30, 2020

Last Update Submit

June 10, 2020

Conditions

Keywords

Low-dose CTCommunity-acquired pneumoniaComputed tomography

Outcome Measures

Primary Outcomes (1)

  • Evaluate the correlation between standard CT and low-dose CT scans for the detection of community-acquired pneumonia.

    A standardized scale CT1-CT4 will be used. The expected correlation percentage is 90%.

    Upon completion, up to 1 year

Secondary Outcomes (2)

  • Threshold value of the infiltration zone size detected by low-dose CT scan compared to standard CT scan.

    Upon completion, up to 1 year

  • Number of infiltration zones of pulmonary parenchyma corresponding to viral pneumonia detected by low-dose CT scan in comparison with standard CT scan.

    Upon completion, up to 1 year

Study Arms (2)

Standard Chest CT

ACTIVE COMPARATOR
Diagnostic Test: Low-dose Chest CT

Low-dose Chest CT

EXPERIMENTAL
Diagnostic Test: Low-dose Chest CT

Interventions

Low-dose Chest CTDIAGNOSTIC_TEST

Patients referred by the primary care physician with suspected pneumonia.

Low-dose Chest CTStandard Chest CT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A referral from the attending physician for a chest CT scan
  • Suspected pneumonia
  • Signed informed consent
  • Over 18 years old
  • Both male and female

You may not qualify if:

  • Pregnant or nursing women
  • Presence of foreign implanted objects in the body at the scan level (including cardiac pacemakers, spine metalware)
  • Patients after surgical intervention at the level of the chest organs
  • Cancer patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Victor Gombolevskiy

Moscow, 109029, Russia

Location

Related Publications (1)

  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

    PMID: 31986264BACKGROUND

MeSH Terms

Conditions

PneumoniaCoronavirus InfectionsCommunity-Acquired Pneumonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesCommunity-Acquired Infections

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Research Officer

Study Record Dates

First Submitted

April 30, 2020

First Posted

May 7, 2020

Study Start

April 25, 2020

Primary Completion

May 22, 2020

Study Completion

May 22, 2020

Last Updated

June 12, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations